These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11392627)

  • 1. Anticholinergic therapy for airway diseases.
    Jacoby DB; Fryer AD
    Life Sci; 2001 Apr; 68(22-23):2565-72. PubMed ID: 11392627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.
    Kistemaker LE; Gosens R
    Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.
    Belmonte KE
    Proc Am Thorac Soc; 2005; 2(4):297-304; discussion 311-2. PubMed ID: 16267352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors in human airways.
    White MV
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1065-8. PubMed ID: 7751523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor subtypes: implications for therapy.
    Barnes PJ
    Agents Actions Suppl; 1993; 43():243-52. PubMed ID: 8368167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic acetylcholine receptors and airway diseases.
    Coulson FR; Fryer AD
    Pharmacol Ther; 2003 Apr; 98(1):59-69. PubMed ID: 12667888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling.
    Kanazawa H
    Curr Opin Pulm Med; 2006 Jan; 12(1):60-7. PubMed ID: 16357581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-agonist and anticholinergic drugs in the treatment of lung disease.
    Proskocil BJ; Fryer AD
    Proc Am Thorac Soc; 2005; 2(4):305-10; discussion 311-2. PubMed ID: 16267353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of anticholinergics in asthma.
    Gosens R; Gross N
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology of cholinergic nerves and treatment with anticholinergics in obstructive airways disease].
    Karwat K
    Pneumonol Alergol Pol; 1997; 65(9-10):685-90. PubMed ID: 9489445
    [No Abstract]   [Full Text] [Related]  

  • 11. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease.
    On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW
    Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.
    Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R
    Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor subtypes in airways.
    Barnes PJ
    Life Sci; 1993; 52(5-6):521-7. PubMed ID: 8441331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticholinergic drugs in the therapy of obstructive airway diseases].
    Windt R
    Med Monatsschr Pharm; 2011 Apr; 34(4):130-7. PubMed ID: 21528530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tiotropium bromide on airway remodeling in a chronic asthma model.
    Kang JY; Rhee CK; Kim JS; Park CK; Kim SJ; Lee SH; Yoon HK; Kwon SS; Kim YK; Lee SY
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):29-35. PubMed ID: 22727154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer?
    Quizon A; Colin AA; Pelosi U; Rossi GA
    Curr Pharm Des; 2012; 18(21):3061-85. PubMed ID: 22564300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling.
    Gosens R; Bos IS; Zaagsma J; Meurs H
    Am J Respir Crit Care Med; 2005 May; 171(10):1096-102. PubMed ID: 15695490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Med Klin (Munich); 2000 Oct; 95(10):552-8. PubMed ID: 11092168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing face of β2-adrenergic and muscarinic receptor therapies in asthma.
    Wasilewski NV; Lougheed MD; Fisher JT
    Curr Opin Pharmacol; 2014 Jun; 16():148-56. PubMed ID: 24922602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.